BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26589824)

  • 1. Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer.
    van Brussel AS; Adams A; Oliveira S; Dorresteijn B; El Khattabi M; Vermeulen JF; van der Wall E; Mali WP; Derksen PW; van Diest PJ; van Bergen En Henegouwen PM
    Mol Imaging Biol; 2016 Aug; 18(4):535-44. PubMed ID: 26589824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
    van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
    Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
    Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis.
    Araste F; Ebrahimizadeh W; Rasooli I; Rajabibazl M; Mousavi Gargari SL
    Biotechnol Lett; 2014 Jan; 36(1):21-8. PubMed ID: 24068505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization.
    Kijanka MM; van Brussel AS; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM; Oliveira S
    EJNMMI Res; 2016 Dec; 6(1):14. PubMed ID: 26860296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast.
    Vermeulen MA; van Deurzen CH; Schroder CP; Martens JW; van Diest PJ
    J Clin Pathol; 2020 Apr; 73(4):204-208. PubMed ID: 31653758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models.
    Huizing FJ; Hoeben BAW; Franssen GM; Boerman OC; Heskamp S; Bussink J
    Mol Pharm; 2019 Feb; 16(2):701-708. PubMed ID: 30550290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells.
    van Lith SAM; Huizing FJ; Franssen GM; Hoeben BAW; Lok J; Doulkeridou S; Boerman OC; Gotthardt M; van Bergen En Henegouwen PMP; Bussink J; Heskamp S
    Mol Pharm; 2022 Oct; 19(10):3511-3520. PubMed ID: 35044182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.
    Wang J; Fang R; Wang L; Chen G; Wang H; Wang Z; Zhao D; Pavlov VN; Kabirov I; Wang Z; Guo P; Peng L; Xu W
    Cell Physiol Biochem; 2018; 47(4):1565-1577. PubMed ID: 29949785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared fluorescence molecular imaging of ductal carcinoma in situ with CD44v6-specific antibodies in mice: a preclinical study.
    Vermeulen JF; van Brussel AS; Adams A; Mali WP; van der Wall E; van Diest PJ; Derksen PW
    Mol Imaging Biol; 2013 Jun; 15(3):290-8. PubMed ID: 23184608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
    Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM
    Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targeting of carbonic anhydrase IX in mice with hypoxic HT29 colorectal tumor xenografts.
    Carlin S; Khan N; Ku T; Longo VA; Larson SM; Smith-Jones PM
    PLoS One; 2010 May; 5(5):e10857. PubMed ID: 20523727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts.
    Garousi J; Huizing FJ; Vorobyeva A; Mitran B; Andersson KG; Leitao CD; Frejd FY; Löfblom J; Bussink J; Orlova A; Heskamp S; Tolmachev V
    Sci Rep; 2019 Oct; 9(1):14907. PubMed ID: 31624303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
    Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
    Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-Infrared Fluorescence Imaging of Carbonic Anhydrase IX in Athymic Mice Bearing HT-29 Tumor Xenografts.
    Li J; Bao B; Liu L; Wang X
    Biomed Res Int; 2016; 2016():6825712. PubMed ID: 27652266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.